David Smoller
InvestorGeneral Partner at Cultivation Capital
St. Louis, Missouri
Writes $100K β $3.5M checks Β· typically $1.8M
About
David Smoller is a life sciences executive who was CEO of Sage Labs, a gene-editing-based contract research organization acquired by Horizon Discovery, where he then served as Chief Business Officer and board member until December 2015. He previously held roles at Sigma-Aldrich Corporation, including Chief Scientific Officer and President of its Research Biotech Business Unit, and founded ProteoPlex (acquired by Merck KGaA) and Genome Systems Inc. (acquired by Incyte Corporation, where he later became Senior Vice President). He holds a doctorate in Molecular Biology and a bachelor's degree in Biology from Emory University.
Invests in
Biotech
Experience
- Washington University in St. Louis Office of Technology Management (Tech Transfer)Entrepreneur in Residencecurrent2025 β present
- BioGenerator VenturesEntrepreneur in Residencecurrent2018 β presentSt Louis, Missouri, United States
- Panome BioCo-Founder/Board Membercurrent2022 β present
- Solis AgrosciencesCo-Founder/Board Membercurrent2022 β present
- Vector Laboratories, Inc.Board Membercurrent2021 β present
- Cultivation CapitalGeneral Partnercurrent2012 β presentGreater St. Louis
- ProteoWiseBoard Member2010 β 2026
- Big Bend Auto Center IncCompany Owner2016 β 2020Richmond Heights, Missouri, United States
- Horizon DiscoveryChief Business Officer and Board Member2014 β 2015
- SAGE LabsChief Executive Officer2013 β 2014Greater St. Louis
- Sigma AldrichChief Scientific Officer2011 β 2012
- Sigma AldrichPresident2007 β 2011
- Sigma AldrichVice president2004 β 2007
- EMD BiosciencesVice President of Corporate Development2004Greater St. Louis
- ProteoplexCEO2002 β 2004St Louis
- Merck Milliporecorp dev VP2002 β 2004
- Incyte Genomicssr. vp of marketing2000 β 2002
- IncyteVp1996 β 2002
- Incyte Pharmaceuticalssr vp1996 β 2001
Education
- Ranken Technical CollegeAuto Technology, Auto Technology2015 β 2017
- Washington University in St. LouisPostdoc, Genome Sciences/Genomics1989 β 1992
- Emory UniversityDoctor of Philosophy - PhD, biology1985 β 1990
- Emory UniversityBS, biology1981 β 1990
Skills & more
+12 more
ImmunologyTechnology TransferBiopharmaceuticalsProteomicsDrug DevelopmentCellProtein ChemistryBusiness StrategyAutomotivePharmaceutical IndustryR&DCommercializationFrom David's professional profile.
Same school
Also attended Washington University in St. Louis130
+ 124 more
Also attended Emory University97
+ 91 more
Shared employers
Also worked at Vector Laboratories, Inc.2
Also worked at Horizon Discovery5
Also worked at Sigma Aldrich1
Also worked at Merck Millipore1
Deals Β· 2
Panome BioBoard seat
via Cultivation Capital Β· filed Nov 2024 Β· $6M raise
Maximum Fidelity Surgical Simulations, Inc.Board seat
via Cultivation Capital Β· filed Sep 2024 Β· $2.2M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at Cultivation Capital
Network6
Investors connected to David in public investor directories β a warm-intro map.























